Increasing Ancestral Diversity in Lupus Trials: Ways Forward

Area of Science:

• Rheumatology
• Clinical Research
• Health Disparities

Background:

• Systemic lupus erythematosus (SLE) disproportionately affects racial and ethnic minorities in the US regarding prevalence, severity, and mortality.
• Existing research on SLE has not adequately included diverse patient populations, leading to significant knowledge gaps.

Purpose of the Study:

• To review the underrepresentation of racial and ethnic minorities in SLE research.
• To highlight the implications of this underrepresentation for disease understanding and therapeutic applicability.
• To emphasize the ethical obligation of the SLE research community to improve diversity in studies.

Main Methods:

• Literature review of existing studies on SLE prevalence, severity, mortality, and research participation.
• Analysis of the impact of underrepresentation on scientific understanding and clinical practice.

Main Results:

• Racial and ethnic minorities are disproportionately affected by SLE but remain underrepresented in clinical research.
• This underrepresentation limits the generalizability of findings and the effectiveness of treatments across diverse populations.

Conclusions:

• There is a critical need to increase the involvement of racial and ethnic minorities in SLE research.
• Future research must actively recruit diverse participants to ensure SLE advancements benefit all affected groups.
• Closing this diversity gap is essential for achieving health equity in SLE management.